Samuel So
Clinical Trials
- Not Recruiting Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
- Recruiting Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
- Not Recruiting Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
- Recruiting Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar Carcinoma
- Recruiting Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
- Not Recruiting Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
- Not Recruiting Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
- Not Recruiting Genetic Analysis of Liver Cancer
- Not Recruiting Microarray Analysis of Gene Expression in Liver Tumors

